DJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. (INO) cratered 37.85% to $1.33 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.02% to 20,601.10 and the Dow Jones Industrial Average rising 0.77% to 44,828.53.
The stock's fall snapped a two-day winning streak.
Inovio Pharmaceuticals Inc. closed 89.21% below its 52-week high of $12.33, which the company reached on July 26th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 0.29% to $156.01, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE.AU)$ rose 0.24% to $25.38.
Trading volume (21.1 M) eclipsed its 50-day average volume of 717,459.
Data source: Dow Jones Market Data, FactSet. Data compiled July 3, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 03, 2025 17:27 ET (21:27 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.